- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT03440762
Atrial Fibrillation Screening and Education Study
Evaluation of a Community-Placed Atrial Fibrillation Screening and Education Program
Studieöversikt
Status
Betingelser
Intervention / Behandling
Detaljerad beskrivning
Background/significance: Atrial fibrillation (AF) is a global epidemic that accounts for 15%-20% of 795,000 strokes occurring annually in the US, at a cost of $3.2 billion per year. Atrial fibrillation-related stroke will rise with the aging population and places enormous strain on healthcare resources and quality of life; yet they are highly preventable, by early detection of AF. Timely treatment reduces AF-related stroke risk by 68%, yet treatment is often delayed because people may not recognize the symptoms of AF or may be asymptomatic. Given the number of people at risk for development of AF and the dire consequences of untreated AF, efforts to promote early detection of AF through proactive screening of older adults at risk for AF have been successfully undertaken in Europe and Australia. However, little is known about the outcomes of conducting programs to screen for and educate people about AF in community settings in the US.
Purpose: The purpose of this descriptive pragmatic study to evaluate the outcomes of a community placed AF screening and education program. Primary outcomes include feasibility, number of participants who screen positive for AF, and changes in participants' Knowledge, Attitudes, and Beliefs about Atrial Fibrillation Self-Monitoring (KABAF-SM) scores from baseline to two-weeks after enrollment.
Methods: Up to 250-participants who have at least two risk factors for developing AF and have no previous diagnosis of AF will be recruited from Midwest community settings and will be screened for AF using a mobile ECG recorder and will receive written information sheet about AF. A portion (up to 125) of those 250 participants will be invited to complete the KABAF-SM at baseline and 2-weeks after enrollment. Participants will have the option to participate in a variety of AF educational activities to reinforce and enhance the written information. Participants will be surveyed about their perceptions of the educational program after the screening and participating in the educational activities.
Evaluation methods: Descriptive statistics will be used to analyze feasibility (enrollment numbers, participants perception of the value of the educational activities, time required for study procedures,and AF detection.T-tests will be used to test for differences between KABAF-SM baseline and two-week scores for those who completed the KABAF-SM.
Studietyp
Inskrivning (Faktisk)
Fas
- Inte tillämpbar
Kontakter och platser
Studieorter
-
-
Minnesota
-
Rochester, Minnesota, Förenta staterna, 55905
- Mayo Clinic in Rochester
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
Tar emot friska volontärer
Kön som är behöriga för studier
Beskrivning
Inclusion :
Any two of the following:
- Hypertension
- Diabetes
- Sleep apnea
- Obesity
- Age > 75 years
- Peripheral arterial disease
- Female
Exclusion :
- Previous diagnosis of atrial fibrillation or atrial flutter
- Uncompensated visual impairment
- Uncompensated hearing impairment
- Inability to communicate verbally in English
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Undersökning
- Tilldelning: N/A
- Interventionsmodell: Enskild gruppuppgift
- Maskning: Ingen (Open Label)
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Övrig: AF awareness education
AF awareness education face to face
|
Participants will receive education about a description of AF, complications, recognition of signs and symptoms of AF, pulse taking, and how to recognize an irregular pulse
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Feasibility-number enrolled
Tidsram: 5 months
|
number of participants enrolled
|
5 months
|
Feasibility-time required for study procedure
Tidsram: 5 months
|
Number of minutes require to perform mobile ECG
|
5 months
|
Participants' perception of the usefulness of the Learning Station activities
Tidsram: 5 months
|
The outcome will be measured by the Participant Perception of Learning Station Activities survey.
This survey is an investigator developed 9-item Survey that asks participants to rate how useful learning activities were to increase their knowledge about atrial fibrillation and to what extent their knowledge about atrial fibrillation has increased after participating in the Learning Station activities.
Psychometric testing has not been performed on this survey.
|
5 months
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
Change in knowledge attitude, and beliefs scores about AF self monitoring from baseline
Tidsram: 5 months
|
Knowledge, attitudes, beliefs about self-monitoring for AF signs and symptoms will be measured by the Knowledge Attitudes and Beliefs about Atrial Fibrillation Self-Monitoring (KABAF-SM) instrument.The KABAF-SM is a 40-item instrument that measures knowledge of AF symptoms (8 items yes/no response, score range 0-8); symptoms not related to AF (6 items yes/no response, score range 0-6); and Likert- responses items (strongly disagree-1 to strongly agree-4) for beliefs about the participant's risk for developing AF(5 items), seriousness of AF,(4 items) benefits (5 items), and barriers (5 items) to monitoring for signs and symptoms of AF.
Total score range for the Likert items is 14-56.
Perceived confidence is measured by 7 items, rated from 0-10 (score range, 0-70) for ability to self-monitor for signs and symptoms of AF.
Higher scores reflect more knowledge and more accurate beliefs and positive attitudes toward self-monitoring.
|
5 months
|
Number of cases of atrial fibrillation detected with portable ECG
Tidsram: 5 months
|
The Alive Cor portable ECG recorder will be used to detect atrial fibrillation.
The device displays the participants rhythm as normal sinus, possible or probable atrial fibrillation, or unable to analyze
|
5 months
|
Samarbetspartners och utredare
Sponsor
Samarbetspartners
Utredare
- Huvudutredare: Pamela J McCabe, Mayo Clinic
Publikationer och användbara länkar
Användbara länkar
Studieavstämningsdatum
Studera stora datum
Studiestart (Faktisk)
Primärt slutförande (Faktisk)
Avslutad studie (Faktisk)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 17-005031
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Förmaksflimmer
-
Pusan National University HospitalHar inte rekryterat ännuHjärtimplanterbar elektronisk enhet | Atrial High Rate EpisodKorea, Republiken av
-
Atrial Fibrillation NetworkDaiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company; Deutsches Zentrum...AvslutadAtrial High Rate EpisoderÖsterrike, Belgien, Bulgarien, Tjeckien, Frankrike, Tyskland, Grekland, Ungern, Italien, Nederländerna, Polen, Portugal, Rumänien, Spanien, Sverige, Ukraina, Storbritannien, Danmark
-
Assiut UniversityIndragenASD2 (Secundum Atrial Septal Defect)
-
Centre Chirurgical Marie LannelongueRekryteringMedfödd hjärtsjukdom | Sinus Venosus Defekt | Sinus Venosus Atrial Septum DefektFrankrike
-
Karolinska InstitutetDanderyd HospitalRekryteringFörmaksflimmer | Förmaksfladder | Supraventrikulärt slag, för tidigt | För tidiga supraventrikulära beats | För tidigt förmakskomplex | Extrasystole, AtrialSverige
Kliniska prövningar på AF awareness education
-
RTI InternationalMedical Research Council, South AfricaRekrytering
-
Children's Hospital Medical Center, CincinnatiAvslutad
-
University of California, Los AngelesAvslutadPåfrestning | Utbrändhet, professionellFörenta staterna
-
Yale UniversityNational Institute on Drug Abuse (NIDA)AvslutadÖka behandlingsföljsamheten vid samtidigt förekommande psykiatriska störningar och narkotikamissbrukNarkotikamissbruk | Psykiatrisk diagnos | Diagnos, dubbel (psykiatri)Förenta staterna
-
Maltepe UniversityRekryteringSpelberoende, videoKalkon
-
Vanderbilt UniversityUniversity of California, Los Angeles; Northwestern UniversityAvslutadMindfulnessFörenta staterna
-
University of DenverNational Institute on Drug Abuse (NIDA)AvslutadSubstansanvändning | MobbingFörenta staterna
-
Evgenia E. PsarrakiAvslutadMajor depressiv sjukdomGrekland
-
University of WashingtonNational Institute on Drug Abuse (NIDA)AvslutadSubstansmissbrukFörenta staterna
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)AvslutadDepression | Förebyggande av skadliga effekter | Tonåring - känslomässigt problemFörenta staterna